BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8440080)

  • 1. Calbindin D-28k immunoreactivity in the temporal neocortex in patients with Alzheimer's disease.
    Ferrer I; Tuñon T; Soriano E; del Rio A; Iraizoz I; Fonseca M; Guionnet N
    Clin Neuropathol; 1993; 12(1):53-8. PubMed ID: 8440080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease.
    Brady DR; Mufson EJ
    J Comp Neurol; 1991 Mar; 305(3):489-507. PubMed ID: 2037717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced density of calbindin-immunoreactive interneurons in the planum temporale in schizophrenia.
    Chance SA; Walker M; Crow TJ
    Brain Res; 2005 Jun; 1046(1-2):32-7. PubMed ID: 15927548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative distribution of parvalbumin, calretinin, and calbindin D-28k immunoreactive neurons in the visual cortex of normal and Alzheimer cases.
    Leuba G; Kraftsik R; Saini K
    Exp Neurol; 1998 Aug; 152(2):278-91. PubMed ID: 9710527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of calbindin-D28K immunoreactive neurons in rat primary motor cortex.
    Sun XZ; Takahashi S; Cui C; Inoue M; Fukui Y
    J Med Invest; 2002 Feb; 49(1-2):35-9. PubMed ID: 11901757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calbindin immunoreactivity in normal human temporal neocortex.
    Ferrer I; Tuñón T; Soriano E; del Rio A; Iraizoz I; Fonseca M; Guionnet N
    Brain Res; 1992 Feb; 572(1-2):33-41. PubMed ID: 1611533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease.
    Ikonomovic MD; Mizukami K; Warde D; Sheffield R; Hamilton R; Wenthold RJ; Armstrong DM
    Exp Neurol; 1999 Nov; 160(1):194-204. PubMed ID: 10630204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of hnRNP B1 in the postmortem temporal cortices of patients with Alzheimer's disease.
    Ishikawa M; Mizukami K; Iwakiri M; Kamma H; Ikonomovic MD; Dekosky ST; Asada T
    Neurosci Res; 2004 Dec; 50(4):481-4. PubMed ID: 15567486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of parvalbumin-, calretinin-, and calbindin-D28k-immunoreactive neurons and fibers in the human entorhinal cortex.
    Mikkonen M; Soininen H; Pitkänen A
    J Comp Neurol; 1997 Nov; 388(1):64-88. PubMed ID: 9364239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calbindin D-28k, parvalbumin and calcitonin gene-related peptide immunoreactivity in the canine spinal cord.
    Chang IY; Kim SW; Lee KJ; Yoon SP
    Anat Histol Embryol; 2008 Dec; 37(6):446-51. PubMed ID: 18637879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calretinin-immunoreactive neurons in the normal human temporal cortex and in Alzheimer's disease.
    Fonseca M; Soriano E
    Brain Res; 1995 Sep; 691(1-2):83-91. PubMed ID: 8590068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative localization of NMDAR1 receptor subunit immunoreactivity in inferotemporal and prefrontal association cortices of monkey and human.
    Huntley GW; Vickers JC; Morrison JH
    Brain Res; 1997 Feb; 749(2):245-62. PubMed ID: 9138725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal lobe pathology in amyotrophic lateral sclerosis. Do amyotrophic lateral sclerosis and Alzheimer's disease share a common etiological factor?
    Smitt PA; Troost D; Louwerse ES; de Jong JM; van Kessel DT; de Leeuw MA
    Clin Neuropathol; 1993; 12(2):88-91. PubMed ID: 8477553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology and reorganization of chandelier cells in the human epileptic sclerotic hippocampus.
    Arellano JI; Muñoz A; Ballesteros-Yáñez I; Sola RG; DeFelipe J
    Brain; 2004 Jan; 127(Pt 1):45-64. PubMed ID: 14534159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of calbindin D-28k immunoreactivity in the hippocampus after adrenalectomy in the seizure sensitive gerbil.
    Hwang IK; Lee HY; Seong NS; Chung HG; Kim JH; Lee HJ; Kim JD; Kang TC; Won MH
    Anat Histol Embryol; 2004 Oct; 33(5):299-303. PubMed ID: 15352884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular basis for the relative resistance of parvalbumin and calretinin immunoreactive neocortical neurons to the pathology of Alzheimer's disease.
    Sampson VL; Morrison JH; Vickers JC
    Exp Neurol; 1997 May; 145(1):295-302. PubMed ID: 9184132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calbindin-D28k content and firing pattern of hippocampal granule cells in amygdala-kindled rats: a perforated patch-clamp study.
    Dietrich D; Podlogar M; Ortmanns G; Clusmann H; Kral T
    Brain Res; 2005 Jan; 1032(1-2):123-30. PubMed ID: 15680950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of the hnRNP A2 and B1 in the hippocampal formations of brains with Alzheimer's disease.
    Mizukami K; Ishikawa M; Iwakiri M; Ikonomovic MD; Dekosky ST; Kamma H; Asada T
    Neurosci Lett; 2005 Sep; 386(2):111-5. PubMed ID: 15993539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.